Human T-lymphotropic virus 2
High prevalence of human T lymphotropic virus 2 (HTLV 2) infection in villages of the Xikrin tribe (Kayapo), Brazilian Amazon region
8
Relationship between the human T- lymphotropic virus and myeloid leukemia, mycobacterium tuberculosis
7
Neutralizing human monoclonal antibodies to conformational epitopes of human T-cell lymphotropic virus type 1 and 2 gp46.
13
Identification and characterization of a new and distinct molecular subtype of human T-cell lymphotropic virus type 2.
12
In vitro CD4+ lymphocyte transformation and infection in a rabbit model with a molecular clone of human T-cell lymphotrophic virus type 1.
6
Seroprevalence of human T-lymphotropic virus antibodies among patients with lymphoid malignancies at a tertiary center in Lagos, Nigeria
6
Human T-Lymphocyte Transformation with Human T-Cell Lymphotropic Virus Type 2
6
Human T-Lymphotropic Virus-1 Associated with Adult T-Cell Lymphoma/ Leukemia and Generalized Expansion of Palatal and Jaw Bones: A Rare Case Report
5
Enhanced specificity of truncated transmembrane protein for serologic confirmation of human T cell lymphotropic virus type 1 (HTLV 1) and HTLV 2 infections by western blot (immunoblot) assay containing recombinant envelope glycoproteins
6
Quantification of the virus host interaction in human T lymphotropic virus I infection
9
Prospective study of cytotoxic T lymphocyte responses to influenza and antibodies to human T lymphotropic virus III in homosexual men Selective loss of an influenza specific, human leukocyte antigen restricted cytotoxic T lymphocyte response in human T lymphotropic virus III positive individuals with symptoms of acquired immunodeficiency syndrome and in a patient with acquired immunodeficiency syndrome
7
Gag Localization and Virus-Like Particle Release Mediated by the Matrix Domain of Human T-Lymphotropic Virus Type 1 Gag Are Less Dependent on Phosphatidylinositol-(4,5)-Bisphosphate than Those Mediated by the Matrix Domain of HIV-1 Gag
9
African Origin of Human T-Lymphotropic Virus Type 2 (HTLV-2) Supported by a Potential New HTLV-2d Subtype in Congolese Bambuti Efe Pygmies
14
Pharmacological inhibition of in vitro infectivity of human T lymphotropic virus type I
8
Human T-Lymphotropic Virus Type 1 Transcription and Chromatin-Remodeling Complexes
14
Line Immunoassay for Confirmation and Discrimination of Human T Cell Lymphotropic Virus Infections in Inconclusive Western Blot Serum Samples from Brazil
12
A monoclonal antibody to human immunodeficiency virus type 1 which mediates cellular cytotoxicity and neutralization.
5
A Human T Lymphotropic Virus Type 1 Carrier Coinfected with Mycobacterium intracellulare and Pneumocystis jirovecii with a Characteristic Compositional Change of Bone Marrow Cells
8
Human T-Lymphotropic Virus Type 2 (HTLV-2) Provirus in Circulating Cells of the Monocyte/Macrophage Lineage in Patients Dually Infected with Human Immunodeficiency Virus Type 1 and HTLV-2 and Having Predominantly Sensory Polyneuropathy
5
APOBEC3A, APOBEC3B, and APOBEC3H Haplotype 2 Restrict Human T-Lymphotropic Virus Type 1
12